MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaut.2023.103159

Медицинская библиотека · Journal of autoimmunity · 2023

Tofacitinib restores psoriatic arthritis fibroblast-like synoviocytes function via autophagy and mitochondrial quality control modulation.

Silvagni Ettore, Missiroli Sonia, Patergnani Simone, Boncompagni Caterina, D'Ugo Clotilde, Garaffoni Carlo, Ciliento Maria Sofia, Lanza Giovanni, Bonora Massimo, Gafà Roberta, Perrone Mariasole, Bortoluzzi Alessandra, Giorgi Carlotta, Govoni Marcello, Scirè Carlo Alberto, Pinton Paolo

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVES

To evaluate the in vitro effect of tofacitinib on autophagy activity of psoriatic arthritis (PsA) fibroblast-like synoviocytes (FLS), and to confirm its activity on inflammatory and invasive properties of FLS and synovial cells, deepening the impact on mitochondrial function.

METHODS

FLS, peripheral blood mononuclear cells (PBMCs), and synovial cells from active PsA patients were cultured with tofacitinib 1 μM or vehicle control for 24 h. Autophagy was measured by Western blot and by fluorescence microscopy. Chemokines/cytokines released into culture supernatants were quantified by ELISA, while invasive properties of FLS by migration assays. Specific mitochondrial probes were adopted to measure intracellular reactive oxygen species (ROS), mitochondrial potential, morphology, turnover and mitophagy. Oxygen consumption rate (OCR), reflecting oxidative phosphorylation, was quantified using the Seahorse technology. Differences were determined by adopting the non-parametric Wilcoxon signed rank test.

RESULTS

18 patients with moderately-to-severely active PsA were enrolled. Tofacitinib significantly increased the levels of the autophagy markers LC3-II and ATG7 in PsA FLS compared to vehicle control, suggesting an increase in spontaneous autophagy activity; no effect was highlighted in PBMCs and synovial cells cultures. Tofacitinib reduced migration properties of PsA FLS, and reduced MCP-1 and IL-6 release into FLS and synovial cells cultures supernatants. Furthermore, tofacitinib decreased intracellular ROS production, increased basal OCR, ATP production and maximal respiratory capacity, and enhanced mitophagy and mitochondrial turnover.

CONCLUSIONS

The JAK inhibitor tofacitinib reduces the pro-invasive and pro-inflammatory properties of PsA FLS. Autophagy induction and mitochondrial quality control modulation by tofacitinib might contribute to FLS function restoration.

Для цитирования: Silvagni Ettore, Missiroli Sonia, Patergnani Simone, Boncompagni Caterina, D'Ugo Clotilde, Garaffoni Carlo, Ciliento Maria Sofia, Lanza Giovanni, Bonora Massimo, Gafà Roberta, Perrone Mariasole, Bortoluzzi Alessandra, Giorgi Carlotta, Govoni Marcello, Scirè Carlo Alberto, Pinton Paolo. Tofacitinib restores psoriatic arthritis fibroblast-like synoviocytes function via autophagy and mitochondrial quality control modulation.. Journal of autoimmunity. 2023. DOI: 10.1016/j.jaut.2023.103159.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.